VPT:CC - Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region
(TheNewswire)
Toronto, Ontario – The Newswire –November 30, 2022 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ; ( OTC:VPTDF) is pleased to announce that it has signed ArcGroup Medical LLC as a distributor for the US - Floridareghion.
Arc Group Medical ( www.arcgmed.com) covers the entireFlorida region and has over five years of direct cardiology salesexperience and around fifteen years cumulatively. Within those fiveyears, Arc Group Medical has been integrated within over fifty sitesacross Florida. This partnership will help diversify Ventripoint’sreach within the US market. The experience working exclusively in thecardiology sector will benefit Ventripoint because of the establishedrelationships the distributor has.
Arc Group Medical President and Regional Distributor,Antonio Cancel, states “We look forward to partnering withVentripoint to introduce this ground-breaking technology to ourhealthcare partners throughout the state of Florida.”
Ventripoint looks forward to the partnership with ArcGroup Medical and is confident that the VMS+ will grow its reachthroughout Florida.
About Ventripoint DiagnosticsLtd.
Ventripoint has become an industry leader in theapplication of AI (Artificial Intelligence) to echocardiography.Ventripoint's VMS products are powered by its proprietary KBRtechnology, which is the result of a decade of development andprovides accurate volumetric cardiac measurements equivalent to MRI.This affordable, gold-standard alternative allows cardiologistsgreater confidence in the management of their patients. Providingbetter care to patients serves as a springboard and basic standard forall of Ventripoint's products that guide our future developments. Inaddition, VMS+ is versatile and can be used with all ultrasoundsystems from any vendor supported by regulatory market approvals inthe U.S., Europe and Canada.
For further information, please contact:
Dr. George Adams
gadams@ventripoint.com
519-803-6937
Neither the TSX Venture Exchange nor its RegulationServices Provider (as
that term is defined in the policies of the TSXVenture Exchange) accepts
responsibility for the adequacy or accuracy of thisnews release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Company.Although the Company believes that the expectations and assumptions on which such forward-looking statements andinformation are based are reasonable, undue reliance should not beplaced on the forward-looking statements and information because theCompany can give no assurance that they will prove to becorrect.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward- lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward- lookingstatements and information contained in this news release are made asof the date hereof and the Company undertakes no obligation to updatepublicly or revise any forward-looking statements or information,whether as a result of new information, future events or otherwise,unless so required by applicable securities laws.
Copyright (c) 2022 TheNewswire - All rights reserved.